Images | Sources | Experiment + Assay | Phenotypes | Human Diseases | ||
---|---|---|---|---|---|---|
fig.2.b, b^1
Peyrot SM et al. (2011) |
Xla Wt + dnrbpj
NF16 (in situ hybridization) |
|
||||
fig.1.b
Peyrot SM et al. (2011) |
Xla Wt + dnrbpj
NF17 (in situ hybridization) |
|
||||
fig.7.h, h^1
Peyrot SM et al. (2011) |
Xla Wt + dnrbpj
NF20 (in situ hybridization) |
|
||||
fig.6.j
Peyrot SM et al. (2011) |
Xla Wt + dnrbpj
NF20-22 (in situ hybridization) |
|
||||
fig.1.n
Peyrot SM et al. (2011) |
Xla Wt + dnrbpj
NF28 (immunohistochemistry) |
|
||||
fig.1.n
Peyrot SM et al. (2011) |
Xla Wt + dnrbpj
NF28 (in situ hybridization) |
|
||||
fig.1.h
Peyrot SM et al. (2011) |
Xla Wt + dnrbpj
NF35/36 (in situ hybridization) |
|
||||
fig.1.k
Peyrot SM et al. (2011) |
Xla Wt + dnrbpj
NF35/36 (in situ hybridization) |
|